EQUI-HIPPO: Feasibility and Acceptability of Horse Therapy for Children, Adolescents and Young Adults in Remission From Medulloblastoma
Study Details
Study Description
Brief Summary
On average, each year in the former region, 60 new patients under the age of 18 are treated for a brain tumor, with an active post-treatment follow-up file of 350 patients. Because of the significant sequelae induced by the disease or the treatments, these patients will very often require rehabilitative care.
The interest of involving the horse in the population of patients cured of a medulloblastoma but with important physical and psychological after-effects is to be able to combine a therapy using animal mediation (equitherapy) and a rehabilitation therapy based on the three-dimensional movement of the horse (hippotherapy).
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: horse therapy
|
Other: horse therapy
equitherapy and hippotherapy once a week during 16 weeks
|
Outcome Measures
Primary Outcome Measures
- number of sessions performed [16 weeks]
number of sessions equitherapy and hippotherapy performed
Eligibility Criteria
Criteria
Inclusion Criteria:
-
complete remission of medulloblastoma and after 5 years of the end of treatment
-
living within 30 km away the riding center and/or less than 1 hour of transport
-
informed consent
Exclusion Criteria:
-
Landsky score below 50% for minors until 16 years old and Karnofsky score below 50% for patients over 16 years
-
major under juridical protection
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- University Hospital, Toulouse
Investigators
- Principal Investigator: Anne-Isabelle BERTOZZI, MD, University Hospital, Toulouse
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- RC31/22/0218